WebOct 27, 2024 · Bain Capital is investing up to $300 million into Cardurion Pharmaceuticals Inc. from both its Bain Capital Life Sciences and Bain Capital Private Equity funds. … WebCardurion Pharmaceuticals , LLC. Cardurion Pharmaceuticals, Inc. Revenue. $4.1 M. Employees. 21. Founded. 2024. Primary Industries. Business Services Research & Development. Funding History. Cardurion Pharmaceuticals raised a total of $300 M in funding over 1 rounds. CEO Peter Lawrence .
Cardurion Pharmaceuticals Announces Investment of up to $300 …
WebAbout us. Cardurion is a clinical-stage cardiovascular biotechnology company developing new therapeutics for the treatment of heart failure and cardiovascular diseases. … WebCarwin Pharmaceuticals is a privately-held specialty pharmaceutical company with a core focus in Primary Care and other specialties like: Allergy, ENT, Pediatrics, Women's Health, Pain Management, Orthopedics, Podiatry, Rheumatology, and Neurology. consumerfallbehindthreshold
Cardurion Pharmaceuticals Announces Investment from Polaris …
WebJul 19, 2024 · About Cardurion Pharmaceuticals Cardurion Pharmaceuticals is a clinical-stage biotechnology company focused on the discovery and development of novel, next-generation therapeutics for the ... WebCardurion Pharmaceuticals is a biotechnology company focused on the discovery and development of next-generation therapeutics for the treatment of heart failure and other … WebSep 7, 2024 · September 7, 2024, 9:05 AM · 1 min read Imara Inc (NASDAQ: IMRA) has agreed to divest tovinontrine (IMR-687) and all other assets related to its PDE9 program to Cardurion Pharmaceuticals Inc. consumer exchange